ProtoKinetix boosts authorized common stock to 600M

ProtoKinetix, Incorporated received stockholder approval by written consent to amend its Articles of Incorporation to increase the total number of authorized common shares from 500,000,000 to 600,000,000.

Accepted by SEC EDGAR 10/10/2025 - 04:58 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ProtoKinetix, Incorporated received stockholder approval by written consent to amend its Articles of Incorporation to increase the total number of authorized common shares from 500,000,000 to 600,000,000. The amendment became effective after sufficient consents were received by 5:00 p.m. Eastern Time on October 6, 2025.

As of the September 5, 2025 record date, there were 389,080,152 shares of common stock outstanding and entitled to 389,080,152 votes, and stockholders holding 57.1% of the outstanding common shares consented to the action.

Insights

Capital structure analyst

ProtoKinetix gained approval to expand authorized shares, adding flexibility but not issuing stock yet.

ProtoKinetix obtained stockholder consent to increase its authorized common stock from 500,000,000 to 600,000,000 shares. This change alters the company’s capacity to issue additional equity in the future but does not itself issue any new shares.

As of the September 5, 2025 record date, 389,080,152 common shares were outstanding, and holders of 57.1% of these shares approved the amendment. The gap between outstanding shares and the new 600,000,000 authorized level indicates room for potential future equity issuance, combinations with other securities, or corporate transactions, depending on future decisions disclosed in subsequent filings.

8-K Event Classification

3 items: 5.03, 5.07, 9.01

3 items

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What corporate change did ProtoKinetix (PKTX) approve in this 8-K?

ProtoKinetix obtained stockholder approval to amend its Articles of Incorporation to increase the total number of authorized shares of common stock from 500,000,000 to 600,000,000.

How many ProtoKinetix (PKTX) shares were outstanding as of the record date?

As of the September 5, 2025 record date, ProtoKinetix had 389,080,152 shares of common stock outstanding and entitled to 389,080,152 votes.

What percentage of ProtoKinetix (PKTX) stockholders approved the increase in authorized shares?

Stockholders holding 57.1% of ProtoKinetix’s outstanding common shares consented to the action increasing authorized common stock to 600,000,000 shares.

How was the ProtoKinetix (PKTX) share increase approved?

The increase in authorized common shares was approved through a consent solicitation of stockholders, with sufficient consents received by 5:00 p.m. Eastern Time on October 6, 2025.

Does the ProtoKinetix (PKTX) amendment issue new shares immediately?

The amendment increases the number of authorized common shares to 600,000,000 but does not, by itself, issue any new shares; it changes the maximum number the company may issue under its Articles of Incorporation.

What exhibit relates to the ProtoKinetix (PKTX) charter amendment?

Exhibit 3.1 is the Certificate of Amendment to the Articles of Incorporation of ProtoKinetix, filed on October 9, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false --12-31 0001128189 0001128189 2025-10-06 2025-10-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: October 6, 2025

ProtoKinetix, Incorporated

(Exact name of registrant as specified in its charter)

Nevada		000-32917		94-3355026
State of Incorporation		Commission File Number		IRS Employer Identification Number

109 W Main Street,

Dalton, OH 44618

Address of principal executive offices

330-445-4971

Telephone number, including Area Code

_______________________________

 Former name or former address if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

See Item 5.07 for information regarding an amendment to the Articles of Incorporation of ProtoKinetix, Incorporated (the “Company”) approved by the stockholders of the Company through a consent solicitation effective October 6, 2025.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On September 15, 2025, the Company solicited the consent of the stockholders of the Company (the “Consent Solicitation”) to approve an amendment to the Company’s Articles of Incorporation to increase the total number of authorized shares of common stock, par value $0.0000053, from 500,000,000 to 600,000,000, as described in the Company’s Consent Solicitation Statement included in its definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on September 15, 2025 (the “Consent Solicitation Statement”). Such approval by the stockholders is herein referred to as the “Action.”

The Action was approved by the requisite vote of a majority of outstanding shares held by the Company’s stockholders as of September 5, 2025 (the “Record Date”) for the Consent Solicitation. As of the Record Date, there were 389,080,152 shares of common stock outstanding and entitled to 389,080,152 votes. The Action is described in more detail in the Consent Solicitation Statement.

1. Action – Approval of Amendment to the Company’s Articles of Incorporation. The stockholders approved the amendment to the Articles of Incorporation to increase the total number of authorized shares of common stock in the Company from 500,000,000 to 600,000,000 based on a total of 222,125,724 shares voted for the Action.

In the aggregate, stockholders holding 57.1% of the Company’s outstanding shares of common stock consented to the Action.

A sufficient number of stockholders consented to approve the Action described above by 5:00 p.m., Eastern Time, on October 6, 2025. As a result, the Consent Solicitation, and the period during which consents could be revoked, concluded as of 5:00 p.m., Eastern Time, on October 6, 2025.

Item 9.01. Financial Statements and Exhibits.

	Exhibit No.		Description
	3.1		Certificate of Amendment to Articles of Incorporation of the Company as filed on October 9, 2025.
	104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 10th day of October 2025.

ProtoKinetix, Inc.
By:	/s/ Clarence Smith
	Clarence Smith, President & CEO